BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12007737)

  • 1. The effects of altered apolipoprotein A-I structure on plasma HDL concentration.
    Sorci-Thomas MG; Thomas MJ
    Trends Cardiovasc Med; 2002 Apr; 12(3):121-8. PubMed ID: 12007737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
    Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
    J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a sequence of apolipoprotein A-I associated with the activation of Lecithin:Cholesterol acyltransferase.
    Sviridov D; Hoang A; Sawyer WH; Fidge NH
    J Biol Chem; 2000 Jun; 275(26):19707-12. PubMed ID: 10781581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids.
    McManus DC; Scott BR; Frank PG; Franklin V; Schultz JR; Marcel YL
    J Biol Chem; 2000 Feb; 275(7):5043-51. PubMed ID: 10671546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferase.
    Hoang A; Huang W; Sasaki J; Sviridov D
    Biochim Biophys Acta; 2003 Feb; 1631(1):72-6. PubMed ID: 12573451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.
    Wong L; Curtiss LK; Huang J; Mann CJ; Maldonado B; Roheim PS
    J Clin Invest; 1992 Dec; 90(6):2370-5. PubMed ID: 1281832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I: structure-function relationships.
    Frank PG; Marcel YL
    J Lipid Res; 2000 Jun; 41(6):853-72. PubMed ID: 10828078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.
    Anthanont P; Asztalos BF; Polisecki E; Zachariah B; Schaefer EJ
    J Clin Lipidol; 2015; 9(3):390-5. PubMed ID: 26073399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.